Pioneering Therapies in Left Atrial Appendage Occlusion and Pulse Field Ablation: The Future is Now

The concomitant atrial fibrillation (AF)ablation and left atrial appendage occlusion (LAAO) device implantation has been recently approved in the US after the publication of the Option Trial. Presentations in this continuing medical education activity will evaluate post study approval real life experiences including safety and efficacy as well as appropriate management and follow up post concomitant AF ablation and LAAO implantation procedure.

Register